Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.846
Buy
RSI(14)
62.562
Neutral
STOCH(KDJ)(9,3,3)
61.089
Neutral
ATR(14)
1.459
High Vlolatility
CCI(14)
40.641
Neutral
Williams %R
41.746
Buy
TRIX(12,20)
12.924
Buy
StochRSI(14)
3.647
Oversold
Search
Apimeds Pharmaceuticals US Inc
APUSAdd to Watchlist
5.150USD
+0.230+4.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
64.77MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+4.67%
5 Days
-8.85%
1 Month
+481.92%
6 Months
+178.38%
Year to Date
+214.02%
1 Year
+195.98%
Key Figures
4.770Open
6.146High
55.75KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.44%Turnover Ratio
4.920Prev. Close
4.150Low
178.00KTurnover
LossP/E Static
0.51P/B
0.00%Div Yield TTM
-7.31%ROA
4.03152wk High
0.44Volume Ratio
-1.39MNet Profit
12.58MShares
-0.5515EPS TTM
--Beta
-7.90%ROE
0.95152wk Low
40.58%Amplitude
--Gross Margin
64.77MMarket Cap
48.54Reward/Risk
9.73%Risk Rate
Apimeds Pharmaceuticals US Inc News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
6.022
Sell
MA10
4.424
Buy
MA20
2.576
Buy
MA50
1.754
Buy
MA100
1.648
Buy
MA200
1.833
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Apimeds Pharmaceuticals US Inc Info
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Ticker SymbolAPUS
CompanyApimeds Pharmaceuticals US Inc
CEOMenon (Vin)
Websitehttps://www.apimedsus.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Apimeds Pharmaceuticals US Inc (APUS)?
The current price of Apimeds Pharmaceuticals US Inc (APUS) is 5.15.
What is the symbol of Apimeds Pharmaceuticals US Inc?
The ticker symbol of Apimeds Pharmaceuticals US Inc is APUS.
What is the 52-week high of Apimeds Pharmaceuticals US Inc?
The 52-week high of Apimeds Pharmaceuticals US Inc is 4.03.
What is the 52-week low of Apimeds Pharmaceuticals US Inc?
The 52-week low of Apimeds Pharmaceuticals US Inc is 0.95.
What is the market capitalization of Apimeds Pharmaceuticals US Inc?
The market capitalization of Apimeds Pharmaceuticals US Inc is 64.77M.
What is the Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS)?
The Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS) is -0.55.